JP2018525427A5 - - Google Patents

Download PDF

Info

Publication number
JP2018525427A5
JP2018525427A5 JP2018510982A JP2018510982A JP2018525427A5 JP 2018525427 A5 JP2018525427 A5 JP 2018525427A5 JP 2018510982 A JP2018510982 A JP 2018510982A JP 2018510982 A JP2018510982 A JP 2018510982A JP 2018525427 A5 JP2018525427 A5 JP 2018525427A5
Authority
JP
Japan
Prior art keywords
arylalkylenyl
alkyl
group
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018510982A
Other languages
English (en)
Japanese (ja)
Other versions
JP6956071B2 (ja
JP2018525427A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/048831 external-priority patent/WO2017040234A1/en
Publication of JP2018525427A publication Critical patent/JP2018525427A/ja
Publication of JP2018525427A5 publication Critical patent/JP2018525427A5/ja
Application granted granted Critical
Publication of JP6956071B2 publication Critical patent/JP6956071B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018510982A 2015-08-31 2016-08-26 置換グアニジン基を含有するイミダゾ[4,5−c]環状化合物 Active JP6956071B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562211896P 2015-08-31 2015-08-31
US62/211,896 2015-08-31
PCT/US2016/048831 WO2017040234A1 (en) 2015-08-31 2016-08-26 IMIDAZO[4,5-c] RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS

Publications (3)

Publication Number Publication Date
JP2018525427A JP2018525427A (ja) 2018-09-06
JP2018525427A5 true JP2018525427A5 (enExample) 2019-10-03
JP6956071B2 JP6956071B2 (ja) 2021-10-27

Family

ID=56853873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018510982A Active JP6956071B2 (ja) 2015-08-31 2016-08-26 置換グアニジン基を含有するイミダゾ[4,5−c]環状化合物

Country Status (5)

Country Link
US (1) US10118925B2 (enExample)
EP (1) EP3344623B1 (enExample)
JP (1) JP6956071B2 (enExample)
CN (2) CN113402518B (enExample)
WO (1) WO2017040234A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102685007B1 (ko) 2015-08-31 2024-07-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 구아니딘 치환된 이미다조[4,5-c] 고리 화합물
BR112019000071A2 (pt) 2016-07-07 2019-07-02 Bolt Biotherapeutics Inc conjugados adjuvantes de anticorpo
EP3504215B1 (en) 2016-08-26 2022-04-06 3M Innovative Properties Company Fused [1,2]imidazo[4,5-c]ring compounds substituted with guanidino groups
US10766896B2 (en) 2017-03-01 2020-09-08 3M Innovative Properties Company Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups
EP3887369B1 (en) * 2018-11-26 2024-05-08 Solventum Intellectual Properties Company N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
EP3937984A1 (en) 2019-03-15 2022-01-19 Bolt Biotherapeutics, Inc. Immunoconjugates targeting her2

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
DK0708772T3 (da) 1993-07-15 2000-09-18 Minnesota Mining & Mfg Imidazo[4,5,-c]pyridin-4-aminer
US5352784A (en) 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
JP4391592B2 (ja) 1996-10-25 2009-12-24 スリーエム カンパニー Th2介在性および関連疾患治療のための免疫応答修飾化合物
US6069149A (en) 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6451810B1 (en) * 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US7163947B2 (en) 2003-03-07 2007-01-16 3M Innovative Properties Company 1-Amino 1H-imidazoquinolines
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
CA2535338C (en) 2003-08-14 2013-05-28 3M Innovative Properties Company Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005051380A1 (en) 2003-11-26 2005-06-09 Biovitrum Ab Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r)
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
EP1765348B1 (en) 2004-06-18 2016-08-03 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006028962A2 (en) * 2004-09-02 2006-03-16 3M Innovative Properties Company 1-alkoxy 1h-imidazo ring systems and methods
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
JP2008535831A (ja) * 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ,インコーポレーテッド 環閉鎖および関連する方法および中間体
ES2429170T3 (es) 2005-11-04 2013-11-13 3M Innovative Properties Company 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos
DK2606047T3 (en) 2010-08-17 2017-03-27 3M Innovative Properties Co COMPOSITIONS AND FORMULATIONS WITH LIPIDIZED IMMUNE RESPONSE-MODIFIING COMPOUND AND PROCEDURES THEREOF
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
US9034336B2 (en) 2011-08-30 2015-05-19 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
KR102685007B1 (ko) 2015-08-31 2024-07-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 구아니딘 치환된 이미다조[4,5-c] 고리 화합물

Similar Documents

Publication Publication Date Title
JP2018525426A5 (enExample)
JP2019524861A5 (enExample)
JP2008503484A5 (enExample)
JP2012523457A5 (enExample)
JP2007517035A5 (enExample)
JP2022510313A5 (enExample)
JP2007517044A5 (enExample)
JP2008530099A5 (enExample)
RU2010126105A (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства
JP2007502293A5 (enExample)
JP2007502288A5 (enExample)
JP2021512150A5 (enExample)
JP2010138190A5 (enExample)
AR067896A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
JP2007512370A5 (enExample)
JP2002512243A5 (enExample)
JP2012505871A5 (enExample)
JP2022538228A5 (enExample)
JP2012528166A5 (enExample)
JP2021531311A5 (enExample)
JP2008529974A5 (enExample)
JP2011503118A5 (enExample)
JP2013523614A5 (enExample)
JP2014525420A5 (enExample)
JP2007511527A5 (enExample)